Biotech · Private company · Pittsburgh, PA, US
Echogenesis Therapeutics Inc
Track this companyFree. Adds Echogenesis Therapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Cell type-specific gene therapy approach for TOMT-linked congenital hearing lossFiscal year 2025 · $305.6KNIH RePORTER 1R41DC022471-01 · fetched Nov 12, 2026